Form 4: Beauty Health Co Executive Granted Restricted Stock Units

Daniel Copell Watson, Chief Revenue Officer of Beauty Health Co, received a grant of restricted stock units vesting over three years.

Summary

• Daniel Copell Watson, the Chief Revenue Officer of Beauty Health Co, was granted restricted stock units on April 9, 2024.
• These restricted stock units vest in one-third increments on each of the first three anniversaries of the grant date, contingent upon continued service.
• Following the transaction, Watson directly owns 808,620 shares of Class A Common Stock.
• Watson also directly owns 243,506 restricted stock units.

Sentiment

Score: 7

Explanation: The document reflects a routine executive compensation matter, which is generally neutral to positive as it incentivizes management. The sentiment is moderately positive.

Positives

• The grant of restricted stock units aligns the executive's interests with the long-term performance of the company.
• The vesting schedule incentivizes continued service and commitment from the Chief Revenue Officer.

Industry Context

Stock grants to executives are a common practice in the beauty and health industry to incentivize performance and retain key personnel. This aligns with standard compensation practices among publicly traded companies.

Comparison to Industry Standards

• Stock grants are a typical component of executive compensation packages in publicly traded companies, including those in the beauty and health sector.
• Comparable companies like Estee Lauder (EL) and L'Oreal (OR) also utilize stock options and restricted stock units as part of their executive compensation plans.
• The vesting schedule of one-third increments annually over three years is a standard vesting arrangement.

Stakeholder Impact

• Shareholders may view the stock grant positively as it aligns executive interests with company performance.
• Employees may see this as a sign of stability and investment in leadership.

Key Dates